Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daratumumab + Thalidomide + Dexamethasone in Relapsed/Refractory Myeloma
NCT03143036Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- May 2018
- Primary completion
- Jul 2019
- Countries
- 4
01
Overview
A Phase 2 trial of daratumumab in multiple myeloma (MM), sponsored by National University Hospital. Status: unknown.
02
Drugs
daratumumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03143036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03143036.